Last updated: 28 August 2024 at 6:15pm EST

Erez Raphael Net Worth




The estimated Net Worth of Erez Raphael is at least $4.92 Million dollars as of 27 August 2024. Mr. Raphael owns over 5,000 units of DarioHealth Corp stock worth over $1,530,277 and over the last 8 years he sold DRIO stock worth over $2,007,915. In addition, he makes $1,382,200 as Chief Executive Officer und Director at DarioHealth Corp.

Mr. Raphael DRIO stock SEC Form 4 insiders trading

Erez has made over 23 trades of the DarioHealth Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of DRIO stock worth $4,400 on 27 August 2024.

The largest trade he's ever made was buying 497,010 units of DarioHealth Corp stock on 29 April 2019 worth over $392,638. On average, Erez trades about 32,135 units every 70 days since 2016. As of 27 August 2024 he still owns at least 1,937,059 units of DarioHealth Corp stock.

You can see the complete history of Mr. Raphael stock trades at the bottom of the page.





Erez Raphael biography

Erez Raphael serves as Chief Executive Officer, Director of the Company. Mr. Raphael served as Chairman of the Board of Directors from November 2014 to July 2018, and as a director from November 2014 to the present. He previously and until October 2012 served as our Vice President of Research and Development. Mr. Raphael has over 17 years of industry experience, having been responsible in his career for product delivery, technology and business development. Prior to joining us, from 2010 to 2012, Mr. Raphael served as Head of Business Operations for Nokia Siemens Networks, where he was responsible for establishing and implementing a new portfolio business unit directed towards marketing and sales of complimentary products. Prior to that, from 1998 to 2010, he held increasingly senior positions at Amdocs Limited (Nasdaq:DOX) where he was ultimately responsible for advising the Chief Technology Officer and implementing matters of overall business strategy. Mr. Raphael holds a B.A. in economics and business management from Haifa University.

What is the salary of Erez Raphael?

As the Chief Executive Officer und Director of DarioHealth Corp, the total compensation of Erez Raphael at DarioHealth Corp is $1,382,200. There are no executives at DarioHealth Corp getting paid more.



How old is Erez Raphael?

Erez Raphael is 46, he's been the Chief Executive Officer und Director of DarioHealth Corp since 2018. There are 13 older and 2 younger executives at DarioHealth Corp. The oldest executive at DarioHealth Corp is Richard Stone, 77, who is the Independent Director.

What's Erez Raphael's mailing address?

Erez's mailing address filed with the SEC is 322 W 57TH ST, #33B, , NEW YORK, NY, 10019.

Insiders trading at DarioHealth Corp

Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern und Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.



What does DarioHealth Corp do?

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.



What does DarioHealth Corp's logo look like?

DarioHealth Corp logo

Complete history of Mr. Raphael stock trades at DarioHealth Corp

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
27 Aug 2024 Erez Raphael
Chief Executive Officer
Kauf 5,000 $0.88 $4,400
27 Aug 2024
1,937,059
20 Aug 2024 Erez Raphael
Chief Executive Officer
Kauf 10,000 $0.94 $9,400
20 Aug 2024
1,932,059
16 Aug 2024 Erez Raphael
Chief Executive Officer
Kauf 10,000 $0.90 $9,000
16 Aug 2024
1,922,059
13 Jan 2023 Erez Raphael
Chief Executive Officer
Verkauf 1,200 $6.21 $7,452
13 Jan 2023
1,112,059
5 Nov 2021 Erez Raphael
Chief Executive Officer
Verkauf 1,000 $19.07 $19,070
5 Nov 2021
838,259
3 Nov 2021 Erez Raphael
Chief Executive Officer
Verkauf 38,340 $18.87 $723,476
3 Nov 2021
839,259
1 Nov 2021 Erez Raphael
Chief Executive Officer
Verkauf 67,083 $18.41 $1,234,998
1 Nov 2021
877,599
15 Jul 2021 Erez Raphael
Chief Executive Officer
Verkauf 1,300 $17.63 $22,919
15 Jul 2021
943,299
19 Jan 2021 Erez Raphael
Chief Executive Officer
Kauf 2,268 $19.77 $44,838
19 Jan 2021
530,768
16 Oct 2020 Erez Raphael
Chief Executive Officer
Kauf 7,187 $13.33 $95,803
16 Oct 2020
528,500
20 Jul 2020 Erez Raphael
Chief Executive Officer
Kauf 15,593 $6.91 $107,748
20 Jul 2020
521,313
8 Jun 2020 Erez Raphael
Chief Executive Officer
Kauf 1,000 $6.02 $6,020
8 Jun 2020
505,720
3 Apr 2020 Erez Raphael
Chief Executive Officer
Kauf 15,146 $5.12 $77,548
3 Apr 2020
504,720
25 Mar 2020 Erez Raphael
Chief Executive Officer
Kauf 1,000 $6.38 $6,380
25 Mar 2020
489,574
12 Feb 2020 Erez Raphael
Chief Executive Officer
Kauf 351,546 $8.40 $2,952,986
12 Feb 2020
488,574
28 Jan 2020 Erez Raphael
Chief Executive Officer
Kauf 15,602 $7.82 $122,008
28 Jan 2020
137,028
23 Dec 2019 Erez Raphael
Chief Executive Officer
Kauf 15,454 $6.35 $98,133
23 Dec 2019
121,426
28 Aug 2019 Erez Raphael
Chief Executive Officer
Kauf 10,000 $0.35 $3,500
28 Aug 2019
2,119,398
9 Jul 2019 Erez Raphael
Chief Executive Officer
Kauf 214,952 $0.47 $101,027
9 Jul 2019
2,109,398
29 Apr 2019 Erez Raphael
Chief Executive Officer
Kauf 497,010 $0.79 $392,638
29 Apr 2019
1,894,446
27 Jan 2019 Erez Raphael
Chief Executive Officer
Kauf 61,969 $0.75 $46,477
27 Jan 2019
1,397,436
20 Nov 2018 Erez Raphael
Chief Executive Officer
Kauf 4,000 $0.84 $3,360
20 Nov 2018
1,335,467
15 Aug 2016 Erez Raphael
Chief Executive Officer
Kauf 3,000 $3.89 $11,670
15 Aug 2016
102,941


DarioHealth Corp executives and stock owners

DarioHealth Corp executives and other stock owners filed with the SEC include: